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Hippocampal neurogenesisRepeated forced swimming test (rFST) may detect gradual effects of antidepressants in adult rats. Antidepres-
sants, as enrichment, affected behavior and neurogenesis in rats. However, the inﬂuence of enrichment on behav-
ioral and neurogenic effects of antidepressants is unknown. Here, effects of antidepressants on rFST and
hippocampal neurogenesis were investigated in rats under enriched conditions. Behaviors of male Wistar rats,
housed from weaning in standard (SE) or enriched environment (EE), were registered during rFST. The rFST
consisted of 15 min of swimming (pretest) followed by 5 min of swimming in the ﬁrst (test), seventh (retest
1) and fourteenth (retest 2) days after pretest. One hour before the test, rats received an intraperitoneal injection
of saline (1 ml/kg), ﬂuoxetine (2.5 mg/kg) or imipramine (2.5 or 5 mg/kg). These treatments were performed
daily until the day of the retest 2. After retest 2, rats were euthanized for the identiﬁcation of markers for
neurogenesis in the hippocampus. Fluoxetine or imipramine decreased immobility in retests 1 and 2, as com-
pared to saline. EE abolished these differences. In EE, ﬂuoxetine or imipramine (5 mg/kg) reduced immobility
time in retest 2, as compared to the test. Independent of the housing conditions, ﬂuoxetine and imipramine
(5 mg/kg) increased the ratio of immature neurons per progenitor cell in the hippocampus. In summary, antide-
pressants or enrichment counteracted the high immobility in rFST. Enrichment changed the effects of antidepres-
sants in rFST depending on the type, and the dose of a substance but failed to change neurogenesis in control
or antidepressant treated-rats. Effects of antidepressants and enrichment on rFST seemed neurogenesis-
independent.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
A process to develop new substances to treat Major Depression re-
quires innovative translational research and more predictive animal
models (e.g., Belzung, 2014). Reﬁnement of the current animal models
may be a strategy to ﬁnd innovative ones (e.g., Berton et al., 2012).
The use of rat forced swimming test (FST, Porsolt et al., 1978) is frequent
in the literature because it is considered uncomplicated, inexpensive,
reliable across laboratories, sensitive and relatively selective for detect-
ing substances with potential activity as antidepressants. Several modi-
ﬁcations of the FST in rats were tried in order to keep the valuable
characteristics of it while overcoming some of its negative aspectsrtin immunoreactive cell; EE,
,Ki-67immunoreactivenucleus;
ive inhibitors ofmonoamine re-
ing test; SE, standard environ-
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).(Borsini et al., 1989; Cryan et al., 2005; Dal-Zotto et al., 2000; Detke
et al., 1997; Kitamura et al., 2004; Vieira et al., 2008). For example, a
modiﬁed version of FST in rats (Cryan et al., 2005; Detke et al., 1995,
1997; Lucki, 1997) allowed for detection of substances such as selective
serotonin reuptake inhibitors (SSRIs) that were ineffective in the classi-
cal protocol developed by Porsolt et al. (1978). In addition, modiﬁed
FST in rats discriminated between the effects of SSRIs and noradrenaline
reuptake inhibitors (NRIs) after subacute (Detke et al., 1995) or chronic
treatment (Cryan et al., 2005; Detke et al., 1997). Subsequent modiﬁca-
tions in FST provided conditions for the discrimination of antidepres-
sants from substances with psychostimulant properties (such as
caffeine, Vieira et al., 2008) or for detecting gradual effects of low
doses of antidepressants over time (repeated FST, Mezadri et al., 2011).
Similar to themodiﬁed FST (e.g. Detke et al., 1995), the repeated FST
(Mezadri et al., 2011) consisted of placing the rat into a tank ﬁlled with
water for 15-min on the ﬁrst experimental day (pretest) followed by a
subsequent 5-min of forced swimming session 24 h later (test). In addi-
tion, the testwas then repeated on the seventh (retest 1) and fourteenth
(retest 2) days after the pretest (Mezadri et al., 2011). In these sessions,
rats adopted a typical posture of immobility (ﬂoating in thewater, mak-
ing only minimal movement necessary to keep the head above water)
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movements (Lino-de-Oliveira et al., 2005; Mezadri et al., 2011; Porsolt
et al., 1978). Repetition shortened latency to immobility and increased
endurance of immobility in the retests as compared to the test
(Mezadri et al., 2011). Antidepressant treatment counteracted the ef-
fects of repetition (Gutiérrez-García and Contreras, 2009; Mezadri
et al., 2011). Since the pharmacological treatment began 1 h prior the
test, and was repeated daily until retest 2, there was three different op-
portunities for the evaluation of drug effect in the same group of rats
(Gutiérrez-García and Contreras, 2009; Mezadri et al., 2011). Therefore,
the within-subject analysis allowed for using a smaller number of rats
compared to the standard protocols because it might detect the effects
of short and long-term treatments in a single group of rats. In addition,
repeated FST provided anopportunity to compare the onset of action for
different treatments.
Despite the potential of repeated FST to detect new antidepressants,
the mechanisms underlying antidepressant action in this test remain
elusive. In other behavioral tests, hippocampal neurogenesis seemed a
requirement to the effects of antidepressants (Santarelli et al., 2003).
In addition, antidepressants increased hippocampal neurogenesis after
long-term treatment (e.g. Keilhoff et al., 2006; Malberg et al., 2000;
Pinnock et al., 2009). Therefore, the present work investigated the cor-
relation between behavior in repeated FST and markers of proliferation
and immature neurons in the hippocampus of adult rats. Hippocampal
neurogenesis, aswell as behavior of adult rats were regulated by chang-
es in the environment (Bjørnebekk et al., 2006, 2008; Brenes et al.,
2008; Brenes-Saenz et al., 2006; Gutiérrez-García and Contreras, 2009;
Simpson et al., 2012). For that reason, in the presentwork pharmacolog-
ical treatments were performed in rats housed in standard or enriched
environment. Previously (Gutiérrez-García and Contreras, 2009;
Mezadri et al., 2011), the lowdoses ofﬂuoxetine or imipramine selected
for this study reduced immobility in repeated FST. Factorial analysis
suggested that active behaviors of rats in repeated FST could discrimi-
nate between distinct classes of antidepressants (Mezadri et al., 2011).
Therefore, active behaviors were also scored in the present study.
2. Method
2.1. Animals
All rats (n = 80) used in this study were supplied by the central vi-
varium facilities of the Federal University of Santa Catarina, and all
procedures were previously approved by the local Committee for Ethics
in Animal Research (CEUA—UFSC, 158/CEUA/PRPE/2011). Male Wistar
rats, all 21 days old (post-weaning, postnatal day 21, PND21) were
housed 4-per-cage, under standard conditions of temperature
(21 ± 1 °C), on reversed 12 h–12 h light–dark cycle (lights on at 6
p.m.) and with ad libitum access to food (Nuvital®) and water during
all experimental period. Reversed light–dark cycle allows for experimen-
tation in rat's active period (e.g. Prager et al., 2011). Behavioral experi-
ments (injections and swimming sessions) were performed between
8 a.m. and noon (i.e. during the dark phase of the reversed light–dark
cycle). During the experimental period, rats were housed in standard
(SE, cages with 41 cm length × 34 cm wide × and 16 cm height) or in
enriched (EE) environments. EE consisted of two different cages of
plexiglass (the large one with 55.5 cm length × 36.5 cm wide ×
40.3 cm height and a small one with 45.7 cm length × 28 cm wide ×
32.6 cm height) connected by a PVC tube (100 mm diameter). Cages
were lined with sawdust and contained several toys such as plastic tub-
ing, small balls, clappers, rope, ramps and toilet paper tubes to shred.
The food and water devices were kept in a box and the toys in another.
2.2. Drugs and injections
Fluoxetine (Sigma-Aldrich Inc., St. Louis, USA; dose 2.5 mg/kg) and
imipramine (Sigma-Aldrich Inc., St. Louis, USA; dose 2.5 or 5 mg/kg)were dissolved in 0.9% NaCl solution (injected in the control group
as well) and administered intraperitoneally (IP, 1 ml/kg). These
substances and doses were selected based on the literature
(Gutiérrez-García and Contreras, 2009; Mezadri et al., 2011).
2.3. Experimental design and forced swimming procedures
On the ﬁrst two days in the laboratory (from PND21 to PND23), all
rats were kept in SE for adaptation to laboratory conditions. From
PND23 on, half of the rats (n = 40) was randomly assigned to the EE
and transferred to the EE cages. Both groups, SE and EE, were main-
tained in their particular environments for 40 days, and after this
time, were submitted to the repeated FST (Mezadri et al., 2011, Experi-
mental Design at Fig. S1). On the 41st day of differential lodging, the rats
(PND64) were exposed to the pretest session of forced swimming
(15 min, in the ﬁrst experimental day) and then randomly assigned to
a particular group of pharmacological treatment: ﬂuoxetine, imipra-
mine 2.5 mg/kg, imipramine 5 mg/kg or saline. Twenty-four hours
later, rats were treated with an IP injection of the selected treatment
and, 1 h later, presented to the test session (5min, second experimental
day). In the following 13days, ratswere kept in their particular environ-
mental condition and treated daily with an IP injection according to
their experimental group initially assigned. The test session (5 min)
was repeated on the 7th day (retest 1) and the 14th day (retest 2). In
these days, pharmacological treatment was completed 1 h before the
sessions of swimming. After retest 2, rats (PND 78) were anesthetized
and perfused transcardially. The repeated FST consisted of individually
placing the rats into a cylindrical tank (50 cm height × 25 cm diameter)
containing clean water at 25 °C (25 cm deep). These conditions of
the test were already described previously (Detke et al., 1995;
Lino-de-Oliveira et al., 2005; Mezadri et al., 2011). After each session
rats were taken out of the water and allowed to dry under a lamp
(40 W, 10 min) before being returned to their home cages. All test ses-
sions were recorded by a webcam (Logitech QuickCam) positioned
70 cm above the tank, to enable posterior evaluation. Behavioral
categories scored were immobility, swimming, climbing and diving
(deﬁnitions in Table S1). An experimenter blind to the treatment
performed the behavioral analyses. The parameters evaluated for each
category were: 1—latency (time elapsed between placing the animal
in the tank and the ﬁrst bout of each behavior observed), 2—frequency
(number of bouts), and 3—duration (summary of the time spent in all
bouts). The behavioral parameters were scored by the software
Ethowatcher® (developed by the Laboratory of Comparative Neuro-
physiology of the Federal University of Santa Catarina, freely available
on www.ethowatcher.ufsc.br, IEB-UFSC, Crispim-Junior et al., 2012).
2.4. Immunohistochemistry procedures and cellular quantiﬁcation
After the retest 2, rats were anesthetized (Urethane 35%) and per-
fused transcardially with a sucrose solution (9.25% in 0.02M phosphate
buffer (PB), pH 7.2, with 0.3 ml of heparin, at 37 °C), followed by 4%
paraformaldehyde in PB. The brains were removed, blocked and post-
ﬁxed for 4 h in the same ﬁxative, transferred to a 0.1 M phosphate-
buffered saline solution (PBS, pH 7.2) and then cut on a vibratome at
40 μm (250 μm apart throughout hippocampus). Sections were stored
in a cryoprotectant at−20 °C, until required for the immunohistochem-
ical reactions to detect Ki-67 (Ki-67-ir) or doublecortin (DCX-ir)
(according to Schiavon et al., 2010). Brieﬂy, all washings and incuba-
tions steps were performed under free-ﬂoating (gentle shaking) and
room temperature (RT), unless otherwise stated. Washing steps
(5 min each) consisted of three changes of 0.1 M PBS plus 0.25% Triton
X-100 (PBST) between incubations. Endogenous peroxidase was
blocked by incubation (30min)with 100%methanol plus 0.3%H2O2 so-
lution. Unspeciﬁc sites were blocked by incubation (90 min) in a solu-
tion containing 1% bovine serum albumin (BSA) in PBST followed by
an overnight incubation (4 °C) with the primary antibody [rabbit anti-
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67 (DRM 004, Acris, Germany), 1:1000 diluted in PBST plus 1% BSA]. In-
cubation (2 h)with secondary biotinylated antibodies (goat anti-rabbit,
Vector Laboratories, Burlingame, CA, USA; 1:1000) were followed
by incubation (1.5 h) with avidin–biotin complex (Vector Laboratories,
1:500). Immunoreactions were visualized using 0.05% DAB (3.3-diami-
nobenzidine, Sigma-Aldrich, St. Louis, MO, USA) plus 0.015% H2O2. Sec-
tions were mounted on gelatin-coated glass slides, air-dried, protected
from light for at least 24 h and then dehydrated in a graded series of al-
cohols and xylene before being coverslipped with DPX (Sigma-Aldrich,
St. Louis, MO, USA). Typical staining of Ki-67-ir (round, dark brown
dots) andDCX-ir (perikarya and processes)were seen in the subgranular
zone of the dentate gyrus of hippocampus (DG, Fig. S2). For each animal,
a section placed in the interval between the bregma (−) 3.3 to (−)
4.7 mm (Paxinos and Watson, 1982) was randomly selected for the
quantiﬁcation of Ki-67-ir. From the same interval, a sectionwas random-
ly selected for the quantiﬁcation of DCX-ir. For random selection, every
section of hippocampus of a given animal was labeled with a number
from 1 to n (n=maximal number of sections available for that animal)
and then selected through generation of random numbers (Min = 1,
Max = n, http://www.random.org/). Therefore, present data represent
number of Ki-67-ir nuclei or DCX-ir cells per section of DG. All measure-
ments were performed at high magniﬁcation (400×, optic microscope
Olympus, BH-2; digital camera attached PixeLINK, Ontario, Canada) to
enable distinction of single nuclei. Quantiﬁcation was performed with
the aid of the software Image J (www.rsweb.nih.gov/ij/). For detailed de-
scription of cell quantiﬁcation see Fig. S3. Pharmacological treatments af-
fected Ki-67-ir more intensely than DCX-ir scores, to highlight these
differences the ratio DCX-ir/Ki-67-ir was also calculated. All data were
expressed as percentage (%) of the control group.
2.5. Statistical analysis
Statistical analyses were performed with the aid of Statistica 8
(Stasoft, Tulsa, OK, USA). Normality and homoscedacity were evaluated
with Kolmogorov–Smirnov and Levene tests, respectively. Unpaired Stu-
dent t-test was used to verify statistical differences between SE and EE
during the pretest session. For each environmental condition (SE or EE),
repeated measures two-way ANOVA (Factors: Treatment, Repetition),
followed by Duncan's test, was performed to compare behavioral param-
eters within test, retest 1 and retest 2. Kruskal–Wallis ANOVA by Ranks
followed byMann–Whitney U test was applied to verify statistical differ-
ences in the gain of body weight and immunohistochemical data. Corre-
lations between immunohistochemical data with behavioral parameters
were evaluated using Spearman Rank Order. Values of P b 0.05 were ac-
cepted as being signiﬁcant in all statistical tests performed.
3. Results
3.1. General remarks
All rats remained healthy (eyes, fur, weight) during the whole peri-
od of the experiment and no external or internal injuries were seen in
the area of the IP injections. In all cages with enrichment, rats seem to
interact with the objects because their positions were altered from
day to day. All rats gained weight over the period of the research, inde-
pendent of the lodging condition or pharmacological treatment
(Table S2). However, over the course of the experiment the rats treated
with ﬂuoxetine housed in EE gained signiﬁcantly (t-Test, p b 0.05) less
weight (9.8 + 1 g) than those housed in SE (15.6 ± 1.3 g).
3.2. Behaviors of male rats in the repeated FST: effects of housing conditions
on the control group
Data of statistical analyses are in Tables S3–S6. In the pretest, the la-
tency to climbing was shorter in EE than in SE while other parametersremained similar between the groups (Table S3). From the test to retest
2, rats of the control group housed in SE displayed reduced latency to
immobility while increased duration and frequency of immobility
(Table S4). Retesting also increased the frequency of swimming of con-
trol rats (Table S5). Scores of climbing were not affected by retesting.
Housing in EE prevented the effects of retesting on immobility and
swimming of control rats (Tables S4 and S5).
3.3. Behaviors ofmale rats in the repeated FST: effects of the antidepressants
in standard housing
Data of statistical analyses are Tables S4–S6. In SE, pharmacological
treatments failed to affect any parameters of climbing (Fig. 1 and
Table S6) while affected the parameters of immobility (Fig. 1
and Table S4) and swimming (Fig. 1 and Table S5). In fact, imipramine
(2.5 mg/kg) reduced immobility time in retest 1 and 2 as compared to
saline (Fig. 1 and Table S4). Imipramine (5mg/kg), aswell as ﬂuoxetine,
increased latency to immobility and reduced immobility time and fre-
quency in retests 1 and 2, as compared to saline (Fig. 1 and Table S4).
Imipramine (5 mg/kg) also reduced the frequency of swimming in the
test and retest 2 (Table S5).
3.4. Behaviors ofmale rats in the repeated FST: effects of the antidepressants
in enriched housing
Data of statistical analyses are in Tables S4–S6. In rats housed in EE,
there were no signiﬁcant differences between pharmacological treat-
ments and saline (Fig. 1 and Tables S4–S6). However, there were sig-
niﬁcant differences between the scores in the test and retests within
a pharmacological treatment. Indeed, treatment with imipramine
(5 mg/kg), as well as ﬂuoxetine, decreased signiﬁcantly immobility
time in retest 2 when compared to the test (Fig. 1 and Table S4). In ad-
dition, ﬂuoxetine increased signiﬁcantly swimming time and frequency
in retests 1 and 2 as compared to the test (Fig. 1 and Table S5). Treat-
ment with ﬂuoxetine also increased the frequency of climbing in retest
2 when compare to the test (Table S6).
3.5. Neurogenesis in the hippocampus ofmale rats submitted to the repeated
FST: effects of pharmacological treatment in different housing conditions
In SE conditions, pharmacological treatment failed to affect signiﬁ-
cantly the percentage of Ki-67-ir (Kruskal–Wallis, H (2, N = 15) =
1.01, p = 0.6, Fig. 2 A) or DCX-ir (Kruskal–Wallis test: H (2, N =
12) = 2.9, p = 0.2, Fig. 2 B) in relation to control. In EE conditions, the
percentage of Ki-67-ir in the DG of rats submitted to repeated FST was
signiﬁcantly lowered after pharmacological treatment (Kruskal–Wallis,
H (2, 15) = 9.8, p = 0.007, Fig. 2 A) while percentage of DCX-ir
remained unchanged (Kruskal–Wallis, H (2, N = 12) = 4.6, p = 0.09,
Fig. 2 B). Indeed, the percentage of Ki-67-ir nuclei in the DG of rats
housed in EE and treated with imipramine (5 mg/kg) or ﬂuoxetine
was signiﬁcantly smaller than in those treated with saline or imipra-
mine (2.5 mg/kg) (Mann–Whitney, p b 0.05, Fig. 2 A). Raw data can
be found in Table S7.
Pharmacological treatment affected signiﬁcantly the ratio DCX-ir/Ki-
67-ir independent of the housing condition (Kruskal–Wallis, H (3, N =
34)= 14.3, p= 0.002, Fig. 2 C). Post hoc analysis indicated that imipra-
mine (5 mg/kg) and ﬂuoxetine increased the ratio DCX-ir/Ki-67-ir, as
compared to saline (Mann–Whitney, p b 0.05, Fig. 2 C). There was no
signiﬁcant correlation between the number of Ki-67-ir nuclei and
DCX-ir cells in the DG neither between these markers and behaviors
scored by rats in the repeated FST (data not shown).
4. Discussion
This study replicated the ﬁndings showing that repeated FST in rats
could detect the gradual effects of low doses of imipramine and
Fig. 1.Duration (s) of immobility (upper panel), swimming (middle panel) and climbing (lower panel) recorded for 5min during the test (T), retest 1 (R1), and retest 2 (R2) inmale rats.
Bars (white=SAL, n=15; light gray= IMI2.5, n=8, dark gray= IMI5, n=6, black=FLX, n=6) representmean±S.E.M. fromSE (left) and EE (right) groups. *= signiﬁcantly different
from respective SAL group, p b 0.05 (Duncan's test); # = signiﬁcantly different from the respective test, p b 0.05 (Duncan's test). Abbreviations: SAL = saline, IMI2.5 = imipramine
(2.5 mg/kg, IP), IMI5 = imipramine (5 mg/kg, IP), FLX = ﬂuoxetine (2.5 mg/kg, IP), SE = standard environment, EE = enriched environment.
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et al., 2011). In addition, it revealed that the enriched environment per
se prevented the effects of retesting on parameters of immobility, simi-
larly to the treatment with the small doses of imipramine or ﬂuoxetine.
However, the enriched environment changed the effects of the pharma-
cological treatments on behavior in substance and dose-related fashion.
Moreover, the treatment with imipramine (5 mg/kg) or ﬂuoxetine for
fourteen days increased the ratio between proliferating cells and new
neurons in the hippocampus indicating that antidepressants favored
differentiation of progenitors. These last effects of the antidepressant
seemed independent of the environmental conditions.
Current procedureswere consistentwith those previously published
(Dal-Zotto et al., 2000; Gutiérrez-García and Contreras, 2009; Mezadri
et al., 2011), rats housed in standard conditions shown in the pretest atypical repertoire for the ﬁrst contact with the forced swimming situa-
tion. Over retesting, the latency to immobility decreasedwhile other pa-
rameters of immobility increased as expected for male rats treated with
saline and housed in a standard environment (Dal-Zotto et al., 2000;
Gutiérrez-García and Contreras, 2009; Mezadri et al., 2011). In those
rats treated with ﬂuoxetine (2.5 mg/kg), anti-immobility effect was vis-
ible earlier (retest 1) than previously reported (retest 2, Mezadri et al.,
2011). The reversed light cycle (lights on at 6 pm) used in the present
study might be a factor relevant for this contrasting ﬁnding. Reversed
light cycle may affect the activity of rats in general (Prager et al.,
2011) and in the traditional FST (Kelliher et al., 2000; Verma et al.,
2010). On the other hand, reversed light cycle seemed not to alter the
onset of imipramine action in repeated FST because current data were
similar to those obtained in rats maintained in regular light cycle
Fig. 2. Number of proliferative cells (Ki-67-ir-nuclei, upper panel) and immature cells
(DCX-ir-perikarya, middle panel) per section of the dentate gyrus of male rats submitted
to the repeated FST (n = 3–7 per group). The ratio proliferative/immature cells (DCX-ir/
Ki-67-ir) per section of dentate gyrus (n = 3–5). Data are expressed as percentage of
the respective SAL group (% Control, dashed horizontal line). Bars (light gray = IMI2.5,
dark gray = IMI5, black = FLX) represent mean ± S.E.M. from SE (left) and EE (right)
groups. * = signiﬁcantly different from respective SAL group, p b 0.05 (Mann–Whitney
test). Abbreviations: see Fig. 1. Means ± S.E.M. of raw data available in Table S7.
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tions, the onset of effect was similar to imipramine and ﬂuoxetine.
The model of repeated FST, based on the factorial analysis of rats
housed in SE conditions (Mezadri et al., 2011), predicted that small
doses of antidepressants would not change any parameter in the test.
However, would prevent an increase of immobility in retests 1 and 2
(putative index for antidepressant detection in repeated FST, Mezadri
et al., 2011). In addition, low doses of SSRIs would increase swimming
time (or the frequency of swimming, or frequency of immobility, or all
of them) whereas other antidepressant substances would increase
climbing time (or latency to immobility, or frequency of climbing, or
all of them) in retests 1 and 2 (Mezadri et al., 2011). In the present
study the small doses of ﬂuoxetine (an SSRI) or imipramine (an NSRI)
failed to change any parameter in the test while prevented the increase
of immobility time over retesting, according to the model. Differing
from the model, parameters of swimming and climbing in repeated
FSTwere similarly affected by both antidepressants. Therefore, differing
from the previous expectation, the scores of active behaviors were not
suitable to discriminate SSRI-type drugs from other antidepressant sub-
stances (e.g. non-selective inhibitors of monoamine reuptake, NSRIs) in
the standard condition.Continuous housing in enrichment fromweaning decreased param-
eters of immobility of rats submitted to the traditional FST in the adult-
hood (Brenes et al., 2008; Brenes-Saenz et al., 2006; Porsolt et al., 1978).
However, current data showed that rats in enriched or standard housing
behaved similarly in the pretest and test (similar to previously
published data Cui et al., 2006; Simpson et al., 2012). Several factors
could account for the disparities between present (and Cui et al.,
2006; Simpson et al., 2012) and other studies (Brenes et al., 2008;
Brenes-Saenz et al., 2006; Porsolt et al., 1978). Strain, sex and age of
rats, as well as the length of the exposure to the enrichment, the size
of the cage and the objects available, may change the aspects of enrich-
ment and its consequences (Simpson and Kelly, 2011). For example,
Brenes et al. (2008) found decreased immobility in male Sprague–
Dawley rats tested in the traditional FST after 11 weeks of enrichment
in cages (120 cm length × 70 cm width × 100 cm height) containing a
running wheel. Studying the same strain of male rats, Simpson et al.
(2012) or Simpson and Kelly (2012) did not observe any modiﬁcation
of behavior in the traditional FST after nine weeks of enrichment
(cage: 54 cm length × 38 cmwidth × 20 cm height) without a running
wheel. In the present study, the conditions of enrichment and behavior-
al output were similar to Simpson et al. (2012) or Simpson and Kelly
(2012). Indeed, the running wheel seemed to be an important element
in the enriched environment for rats (Bjørnebekk et al., 2006, 2008).
The absence of a running wheel could explain why the enrichment
failed to reduce immobility time in the pretest and test sessions of the
repeated FST.
Despite the initial lack of effect in the pretest and test, enrichment
prevented the behavioral effects of retesting in the repeated FST. Indeed,
enrichment lowered the values of immobility in the saline's group
during retests 1 and 2 producing a putative “ﬂoor effect” eliminating
signiﬁcant differences between saline and antidepressants seen in the
standard conditions. Absence of antidepressant action on rats
housed in enriched environment was seen previously (Simpson and
Kelly, 2012; Simpson et al., 2012). Despite the “ﬂoor effect”, imipramine
(5mg/kg) and ﬂuoxetine progressively reduced immobility from test to
retest 2 indicating that the enrichment preserved thewithin effects. The
within effects of imipramine observed in enrichment seem dose-
dependent once that the within effects of the dose 2.5 mg/kg were ab-
sent in enriched-housed group. In addition, enrichment appeared to in-
ﬂuence the within effects of imipramine and ﬂuoxetine on behavior in
repeated FST in different ways: 1—affected only anti-immobility effects
of imipramine while 2—potentiated the proactive effects of ﬂuoxetine.
Together these data indicate that features of environments may change,
favor or impair the response of the subjects to antidepressants. The in-
terference of the environmental conditions on the effects of antidepres-
sants may help to explain some incoherent ﬁndings in preclinical and
clinical trials (e.g. Belzung, 2014).
Enrichment and antidepressants may affect several mutual aspects
of brain function such as hippocampal neurogenesis (for review e.g.
Tanti and Belzung, 2013). In this work, eight weeks housed in enrich-
ment failed to affect the markers of proliferation or immature neurons
in the DG of adult Wistar rats submitted to the repeated FST. The lack
of effects of the environment on marker of neurogenesis could be relat-
ed to several different methodological factors (for review see e.g.
Simpson and Kelly, 2011). Besides the absence or a running wheel
(Bjørnebekk et al., 2006), the length of enrichment and the strain of
rats may be relevant to the inﬂuence of enrichment on neurogenesis
(Birch et al., 2013). Indeed, in adult Wistar rats the proliferation in the
hippocampus remained unchanged after six weeks of housing in an
enriched environment (Birch et al., 2013). Concerning to immature
neurons, six weeks of an enrichment favored the short term survival
(within two weeks after birth) without affecting long-term one (six
weeks after birth) of new cells in the DG of Wistar rats (Birch et al.,
2013). These last data could help to explain the lack of signiﬁcant differ-
ences between the numbers of immature cells in the DG of control rats
in standard or enriched housing for eight weeks.
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the actions of the antidepressant treatment on markers for
neurogenesis in the DG. The treatment with imipramine (5 mg/kg) or
ﬂuoxetine during the two weeks of the repeated FST decreased the
number of proliferating cells in the DG, which was signiﬁcant in enrich-
ment. Regarding immature neurons, treatment with antidepressants
failed to affect consistently the number of DCX-ir cells in the DG of
Wistar rats housed in standard or enriched environment. These results
were surprising because the literature is plenty of evidence showing
pro-proliferative and pro-neurogenic effects of antidepressants (e.g.
Keilhoff et al., 2006; Klomp et al., 2014; Malberg et al., 2000;
Marcussen et al., 2008; Santarelli et al., 2003). However, factors such
as the characteristics of the rat (strain, sex and age), the presence of
the intermittent stress (repeated FST), and the doses and length of
the antidepressant may help to explain these disparities. Indeed,
antidepressants increased proliferation and neurogenesis in the hippo-
campus of male Wistar rats only when administered for longer than
two weeks in rats younger than 65 days (Klomp et al., 2014;
Marcussen et al., 2008; Mateus-Pinheiro et al., 2013). Moreover, ﬂuoxe-
tine in the doses of 10 mg/kg increased proliferation in the DG of
Sprague–Dawley rats after fourteen days of treatment while the doses
of 2.5 and 5 mg/kg failed to affect it (Pinnock et al., 2009). Therefore,
in the present work the doses and the length of the treatment were suf-
ﬁcient to produce behavioral effects, but not enough to reveal increased
neurogenesis in the DG. In addition, repeated FST could have affected
hippocampal neurogenesis (Vega-Rivera et al., 2014) impairing the ac-
tions of the antidepressants on the number of newborn neurons.
Twoweeks of imipramine (5mg/kg) or ﬂuoxetine (2.5mg/kg) were
the most effective treatments to reduce immobility in repeated FST.
These treatments reduced Ki-67-ir while failed to change DCX-ir in
the DG increasing the ratio Ki-67-ir/DCX-ir in standard or enriched
housing conditions. The increased ratio between proliferating and im-
mature neuronsmarkersmay indicate an increase in that differentiation
of progenitors into newborn neurons or, alternatively, an increase in
newborn neurons survival. This last possibility seemed feasible once
that the treatment with imipramine or ﬂuoxetine (10 mg/kg for two
weeks) increased the number of cells still alive and mature six weeks
after their birth (Mateus-Pinheiro et al., 2013). Therefore, more appro-
priated experiments (for example, using BrdU) should be performed
in order to verify these hypotheses. The lack of correlation between
the numbers of proliferating or immature neurons with behavior in re-
peated FST indicated absence of a linear relationship between these
both consequences of the treatments with antidepressants. In fact,
antidepressant-like effects in FST may be seen even after the inhibition
of the hippocampal neurogenesis (Zhang et al., 2012).
5. Conclusion
In summary, behavioral outcome in repeated FST in rats depended
on the housing conditions. Housing in enrichment impaired increased
immobility over the repetition of the swimming sessions. In addition,
enrichment affected the behavioral outcome of antidepressant treat-
ment. However, the inﬂuence of enrichment on behavioral effects of an-
tidepressants was not general but depended on the substance and the
doses administered to the rats. In enriched conditions, twoweeks treat-
ment with antidepressants decreased the number of proliferating cells
and failed to change the number of immature neurons in the DG. Con-
versely, fourteen days of treatment with antidepressants increased the
ratio between the number of proliferating cells and immature neurons
in the DG independent of housing conditions. As far as known, the pres-
ent study is the ﬁrst investigation of the effects of antidepressants
associated to enrichment on parameters of neurogenesis in the DG. Fu-
ture experiments should be done in order to understand why the asso-
ciation of the two pro-neurogenic stimuli reduced the number of
proliferating cells and failed to change the number of immature neurons
in the hippocampus of rats subjected to the repeated FST.Authors' contribution
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